We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFPT
1051
DELISTED
Proofpoint, Inc.
PFPT
| $392K | ﹤0.01% |
4,489
-907
| -17% | -$80.6K |
|
1052
Ingevity
NGVT
$2.56B
| $390K | ﹤0.01% |
6,237
-763
| -11% | -$45.2K |
|
1053
Seres Therapeutics
MCRB
$50.6M
| $389K | ﹤0.01% |
1,211
+84
| +7% | +$23K |
|
1054
Semtech
SMTC
$12.9B
| $388K | ﹤0.01% |
10,325
-1,285
| -11% | -$47.9K |
|
|
WP
1055
DELISTED
Worldpay, Inc.
WP
| $387K | ﹤0.01% |
5,495
-478
| -8% | -$32.6K |
|
1056
Teledyne Technologies
TDY
$30.2B
| $386K | ﹤0.01% |
2,428
-207
| -8% | -$30.1K |
|
1057
Gentex
GNTX
$5.07B
| $383K | ﹤0.01% |
19,348
-1,878
| -9% | -$34.1K |
|
|
TSE
1058
DELISTED
Trinseo
TSE
| $383K | ﹤0.01% |
5,702
+1,713
| +43% | +$114K |
|
1059
ANI Pharmaceuticals
ANIP
$1.79B
| $382K | ﹤0.01% |
7,280
+479
| +7% | +$22.8K |
|
1060
Signet Jewelers
SIG
$3.48B
| $382K | ﹤0.01% |
5,741
+147
| +3% | +$9.04K |
|
|
ACHN
1061
DELISTED
Achillion Pharmaceuticals
ACHN
| $382K | ﹤0.01% |
85,073
+4,554
| +6% | +$20.2K |
|
|
WFT
1062
DELISTED
Weatherford International plc
WFT
| $381K | ﹤0.01% |
83,181
-6,859
| -8% | -$28.3K |
|
1063
Axalta
AXTA
$6.78B
| $380K | ﹤0.01% |
13,128
-592
| -4% | -$17.9K |
|
1064
Oceaneering
OII
$4.79B
| $380K | ﹤0.01% |
14,447
-1,206
| -8% | -$29.2K |
|
1065
Pacific Biosciences
PACB
$435M
| $379K | ﹤0.01% |
72,229
+16,798
| +30% | +$72.2K |
|
|
WDR
1066
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $379K | ﹤0.01% |
18,881
-1,683
| -8% | -$32.4K |
|
1067
Corpay
CPAY
$23.8B
| $378K | ﹤0.01% |
+2,445
| New | +$359K |
|
|
INSY
1068
DELISTED
Insys Therapeutics, Inc.
INSY
| $378K | ﹤0.01% |
42,596
+3,451
| +9% | +$35.6K |
|
1069
Paycom
PAYC
$6.47B
| $377K | ﹤0.01% |
5,029
+673
| +15% | +$48.2K |
|
|
KLXI
1070
DELISTED
KLX Inc.
KLXI
| $377K | ﹤0.01% |
8,442
-1,593
| -16% | -$67.6K |
|
1071
Liberty Latin America Class A
LILA
$1.5B
| $376K | ﹤0.01% |
24,683
+2,184
| +10% | +$35.3K |
|
|
ILG
1072
DELISTED
ILG, Inc Common Stock
ILG
| $376K | ﹤0.01% |
14,076
+3,093
| +28% | +$81.8K |
|
|
TWTR
1073
DELISTED
Twitter, Inc.
TWTR
| $367K | ﹤0.01% |
21,758
-937
| -4% | -$16.4K |
|
1074
Churchill Downs
CHDN
$5.84B
| $361K | ﹤0.01% |
10,518
-1,782
| -14% | -$57.1K |
|
1075
Jabil
JBL
$33.7B
| $360K | ﹤0.01% |
12,610
-1,314
| -9% | -$39.7K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.